SCHEMBL872787

SCHEMBL872787

CCC(C)C(=O)OC(C)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.51
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
FFAR1 O14842 2/20 0.43
KLK7 P49862 1/20 0.43
LMNA P02545 3/20 0.42
HSD17B10 Q99714 2/20 0.42
MMP8 P22894 1/20 0.41
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
POLB P06746 1/20 0.41
APAF1 O14727 1/20 0.41
MAPT P10636 1/20 0.41
GAA P10253 1/20 0.41
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
CHRM5 P08912 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14258829 0.91 HCAR2 (0.40) HCAR2KMT2AMEN1FFAR1LMNA
SCHEMBL2740659 0.90 MAPT (0.50) HCAR2FFAR1MAPTGAACYP1A2
SCHEMBL13704261 0.87 HCAR2 (0.46) HCAR2KMT2AMEN1FFAR1KLK7
SCHEMBL20959848 0.86 HCAR2 (0.49) HCAR2KMT2AMEN1FFAR1HSD17B10
SCHEMBL5941064 0.86 HCAR2 (0.51) HCAR2KMT2AMEN1FFAR1KLK7
SCHEMBL2740686 0.86 LMNA (0.46) KMT2AMEN1FFAR1KLK7LMNA
SCHEMBL9329240 0.85 MAPT (0.50) HCAR2KMT2AMAPTALDH1A1TP53
SCHEMBL9329235 0.85 MAPT (0.50) HCAR2KMT2AMAPTALDH1A1TP53
SCHEMBL2740694 0.84 ACHE (0.41) HCAR2KMT2AMEN1LMNAPOLB
SCHEMBL9547865 0.84 ESR1 (0.46) LMNAHSD17B10CHRM2CHRM1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
US-12121025-B2 Antimicrobial composition THE PROCTER & GAMBLE COMPANY (US) 2024-10-22 US disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
US-20230350290-A1 PATTERN FORMING METHOD, KIT, AND RESIST COMPOSITION FUJIFILM CORPORATION (JP) 2023-11-02 US disclosed
US-20230333478-A1 PATTERN FORMING METHOD, METHOD FOR PRODUCING ELECTRONIC DEVICE, AND KIT FUJIFILM CORPORATION (JP) 2023-10-19 US disclosed
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP disclosed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
US-11747727-B2 Chemical liquid, chemical liquid storage body, pattern forming method, and kit FUJIFILM CORPORATION (JP) 2023-09-05 US disclosed
US-11733611-B2 Pattern forming method, method for producing electronic device, and kit FUJIFILM CORPORATION (JP) 2023-08-22 US disclosed
US-20070218406-A1 Acid generator; exposure to actinic radiation FUJIFILM CORPORATION (JP) 2007-09-20 US disclosed
EP-1827370-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR Showa Denko K.K. (JP) 2007-09-05 EP disclosed
EP-1771407-A1 4-HEPTEN-2-YL SALICYLATE AND ITS USE AS A FRAGRANCE INGREDIENT Givaudan SA (CH) 2007-04-11 EP disclosed
US-20060165622-A1 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-07-27 US disclosed
WO-2006068276-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR SHOWA DENKO K.K. (JP) 2006-06-29 WO disclosed
WO-2006007755-A1 4-HEPTEN-2-YL SALICYLATE AND ITS USE AS FRAGRANCE INGREDIENT GIVAUDAN SA (CH) 2006-01-26 WO disclosed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 HCAR2 2574/4885KMT2A 2697/4885MEN1 2644/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 HCAR2 2574/4885KMT2A 2697/4885MEN1 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.